• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Respiratory Tripledemic 2022-23: Expert Update, Top Challenges


Distinguishing between influenza, COVID-19, and RSV and persuading vaccine-weary patients to get vaccinated are some of the challenges this season, says William Schaffner, MD.

"This has certainly been a distinctive season," said William Schaffner, MD, to Patient Care Online when asked about the current status of the 2022-2023 respiratory virus season.

This season is unique with the cocirculation of influenza, COVID-19, and respiratory syncytial virus (RSV). The "tripledemic," as it has been named, has brought challenges to clinicians caring for infected persons, such as diagnosing between the 3 respiratory diseases and persuading a vaccine weary population that they should get vaccinated, both with the influenza vaccine and the updated COVID-19 boosters. Below, Dr Schaffner gives a brief update on the current respiratory virus season and shares what his top challenges have been so far.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.